A Practical Guide to Using Biologics in Pediatric Dermatology

Area of Science:

• Pediatric Dermatology
• Immunology
• Inflammatory Diseases

Background:

• Psoriasis, HS, AD, and CSU are common chronic inflammatory skin conditions in children.
• Biologics are increasingly used, but provider concerns about pediatric safety and efficacy persist.

Purpose of the Study:

• To provide a practical guide for initiating biologic therapy in pediatric patients with psoriasis, HS, AD, and CSU.
• To establish a methodological framework focusing on baseline work-up, monitoring, and dosing.

Main Methods:

• Review of emerging evidence on biologic safety and efficacy in pediatric populations.
• Development of a framework for clinical management, including specific considerations for children.

Main Results:

• Emerging evidence supports the safety and efficacy of biologic therapies in pediatric patients.
• A structured approach to initiating and monitoring biologics can address provider concerns.

Conclusions:

• Biologic therapy is a viable and safe treatment option for pediatric inflammatory skin diseases.
• A standardized framework is crucial for optimizing biologic use and addressing safety concerns in children.